查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1834197

大肠桿菌检测市场（按检测方法、最终用户、产品类型、技术和样本类型）—2025-2032 年全球预测

E. Coli Testing Market by Test Method, End User, Product Type, Technology, Sample Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年大肠桿菌检测市场规模将成长至 24.3 亿美元，复合年增长率为 10.49%。

主要市场统计数据
基准年2024年 10.9亿美元
预计2025年 12.1亿美元
预测年份：2032年 24.3亿美元
复合年增长率（%） 10.49%

对不断发展的大肠桿菌检测环境进行全面的方向性分析，强调分析的严谨性、操作的弹性和跨部门的适用性

大肠桿菌是公共卫生监测、临床诊断以及食品和水安全监测中的关键微生物，需要从快速现场检测到灵敏的实验室确认的一体化检测生态系统。过去十年，技术进步加快了周转时间，同时，监管和消费者审查的不断加强也创造了一个以准确性、速度和可追溯性为主导的采购和研发决策环境。实验室和最终用户现在不仅必须评估分析效能，还必须评估通量、易用性、供应弹性和长期总拥有成本等营运因素。当诊断结果导致临床干预、污染事件引发召回或营业单位必须证明合规性以保护公众健康时，这些考虑因素尤其重要。

从广泛监测转向有针对性的缓解策略需要更清晰地了解检测方法在不同样本类型和环境下的表现，以及产品类型和技术如何与工作流程的实际情况相互作用。随着相关人员对互通性、数位资料收集和标准化报告的需求日益增长，投资重点正转向能够在整个体系中进行检验并整合到企业系统中的解决方案。因此，能够将强大的检测性能与可扩展的仪器和可靠的耗材相结合的市场参与企业将更有能力满足监管机构、临床医生和供应链合作伙伴日益增长的需求。更可携式的分子平台和增强型生物感测方法的引入将进一步拓宽应用途径，但在广泛采用之前也需要仔细评估验证证据和品质保证实践。

透过分散的分子诊断、增强的生物感测和整合的数位工作流程再形成大肠桿菌检测的重大系统转变

过去几年，实验室和相关领域一直在重新定义大肠桿菌检测的构想、采购和操作方式。曾经仅在中心实验室使用的快速分子检测技术，如今正朝着近患者和现场应用的方向发展，挑战着传统的培养确认作用，同时能够在疫情爆发时实现快速决策。同时，生物感测器技术也得到了发展，支持供应链和公共设施中的即时筛检，从而缩短了检测延迟，并提供持续监测能力，从而提升情境察觉。

同时，数位数位资料管理与实验室自动化的整合为在不增加人员的情况下进行高通量检测开闢了新途径。这种数位化主干支持改进的可追溯性，促进监管报告，并有助于协调不同最终用户的结果。同时，试剂和套件的技术创新专注于简化工作流程和提高不同样本基质的稳健性，从而促进实验室检测转化为现场友善的格式。监管环境和认证要求也在朝着接受快速分子和免疫检测的方向发展，促使供应商和实验室投资于符合不断发展的指导方针的验证框架。总而言之，这些转变促使供应商重组其产品组合，并促使最终用户重新评估其检测策略，以兼顾速度、准确性和营运效率。

评估关税主导的供应链压力如何推动策略供应商多元化、近岸外包和加强采购保障

美国新关税的实施对大肠桿菌检测生态系统产生了明显的连锁反应，影响了仪器、套件和试剂的筹资策略和供应链规划。某些检测设备和关键耗材的进口关税上调，促使买家重新评估供应商多元化，加快替代製造商的资格审核，并探索国内采购和近岸外包选项，以降低跨境成本波动带来的风险。这种重新平衡对供应商和最终用户都产生了影响，因为采购週期延长，而相关人员则寻求能够提供价格稳定和库存保障的合约。

此外，关税环境也影响与在地化製造能力和经销伙伴关係相关的投资决策。拥有灵活供应商网路和成熟区域分销商的组织在保持交货和服务水准的连续性方面获得了相对优势。同时，保持合规性的需求限制了组件的快速替换，并迫使实验室管理人员在评估新供应商资格时投资于检验活动。总体而言，关税的累积影响凸显了供应链弹性、合约风险分担和主动库存管理的重要性，以确保临床检测、食品检测和水质检测领域的检测营运不间断。

深入的細項分析揭示了测试方法、最终用户需求、产品类型、技术和样本矩阵如何推动采用和检验优先级

要了解市场，需要仔细注意检测方法、最终用户、产品类型、技术选择和样本类型如何相互作用，从而影响采用路径和投资重点。检测方法包括生物感测器、传统培养方法、免疫测量和分子检测。在分子检测领域，数位PCR、PCR和即时PCR等技术在灵敏度、通量和操作复杂性之间各有优劣。这些差异会影响偏好快速即时筛检的环境，以及偏好集中式确认的环境。

在研究最终用户动态时，市场包括学术研究、临床诊断、食品工业和水质检测。临床诊断进一步细分为诊断实验室和医院，每个行业都有其独特的监管和工作流程限制。食品业，包括乳製品、肉类、家禽和加工食品，由于结果获取时间和召回风险，人们对快速筛检的兴趣日益浓厚。水质检测细分为饮用水和污水监测，不同的样品基质和合规制度会影响分析方法的选择。按产品类型划分，仪器、套件和试剂构成了解决方案的支柱，而采购决策通常涉及平衡资本投资与消耗品成本和服务合约。从技术角度来看，层析法、酵素结合免疫吸附试验、质谱法和聚合酵素链锁反应等基本分析平台是检测策略的基础，选择这些平台取决于基质的复杂性和对确认证据的需求。最后，不同类型的样本（临床样本、食品样本和水样本）具有不同的分析前要求和抑制特性，需要客製化萃取、浓缩和验证方法，以确保可靠的检测。这些细分维度之间的相互作用指南采用，确定创新的优先级，并在市场相关人员中建立客户价值提案。

从区域角度强调法律规范、基础设施投资和市场成熟度将如何决定世界不同地区的测试采用情况

由于管理体制、供应链基础设施和公共卫生重点的差异，区域动态影响大肠桿菌检测的需求和能力。在美洲，成熟的诊断生态系统和既定的监管途径支持分子检测和自动化平台的快速应用。大型集中式实验室的存在与人们对分散式检查解决方案日益增长的兴趣并存，旨在缩短疫情爆发时的反应时间。

在欧洲、中东和非洲，监管协调工作和不同的市场成熟度造就了复杂的环境，各国对先进技术的采用率可能有显着差异。在多个司法管辖区，对水源产业和食品安全项目的投资正成为更高的优先事项，导致对实验室确认技术和现场筛检工具的需求增加。在亚太地区，快速的工业化和不断扩大的消费市场推动了食品和水检测需求的成长，而对实验室基础设施和国内製造能力的大量投资则加速了新检测平台的采用。这些地区差异凸显了根据当地情况客製化市场准入、监管策略和供应链方法的重要性，以确保最大限度地吸收并维持服务水准。

策略竞争模式显示技术创新、服务整合和监管回应如何塑造大肠桿菌检测领域的供应商优势。

大肠桿菌检测领域的竞争动态以技术主导的差异化与服务导向的价值提案相结合为特征。市场参与企业专注于平台整合、供应链稳定以及与临床、食品和水务领域终端用户的伙伴关係，以将其解决方案融入日常工作流程。投资活动主要集中在扩展分子诊断产品组合、提升生物感测器在现场应用的效能，以及开发可减少实验室时间和降低复杂性的耗材。设备供应商和耗材製造商之间通常会结成策略联盟，供应商旨在提供端到端解决方案，以简化实验室验证和采购决策。

同时，企业正在投资监管和品质体系，以支持核准不同司法管辖区的市场，因为他们认识到本地化审批和在特定基质研究中的卓越表现会影响买家信心。维护合约、远距离诊断和培训计划等服务已成为降低客户营运风险的差异化因素。能够提供可靠的分析性能证据、响应迅速的本地支援和可预测的供应链的公司往往在采购週期中获得优先考虑。随着买家寻求能够全面解决速度、准确性和营运弹性的解决方案，分析化学、样品处理和数据整合领域的持续技术创新将推动下一波竞争优势。

为供应商和最终用户提供实用策略，以增强弹性、加速采用并加强整个测试路径中的验证和支援能力

产业领导者可以采取果断行动，透过调整投资和营运策略，使其与不断变化的最终用户期望和供应链现实一致，从而巩固自身地位。首先，实现供应商网路多元化，并筛选关键设备、套件和试剂的合格替代製造商，可以降低关税波动和物流中断带来的风险，同时缩短供应中断时的恢復时间。其次，投资分子检测能力，尤其是兼顾灵敏度和易用性的平台，可以加快临床和食品安全领域的决策速度，并在不牺牲确认途径的情况下支持检测的分散化。

第三，优先进行所有相关样本类型和技术的验证研究，包括比较生物感测器、免疫测量、层析法、质谱法和基于PCR的方法，以增强买家信心并促进监管申报。第四，透过远端监控、预测性维护和可互通的资料格式增强服务和数位集成，可提高运作和可追溯性。第五，在关键市场建立区域製造或经销伙伴关係，可以缩短供应线并提高对当地监管要求的应对力。最后，与营业单位、食品加工商、医院和公共卫生机构开展合作项目，共同开发工作流程和培训计划，可以加速技术应用，并使各组织成为风险缓解和疫情应对方面值得信赖的合作伙伴。

结合初步访谈、文献综合、检验最后覆核和供应链分析的严格多方法研究框架，可产生可行的见解

本分析所依据的研究组装多方法论，旨在整合来自不同资讯来源的洞见，同时确保分析的严谨性和可重复性。主要资料收集包括对临床、食品和水质检测领域的实验室主任、采购负责人、监管专家和研发科学家进行结构化访谈，以了解操作限制、检验实践和采购驱动因素。除了这些定性资讯外，我们还全面查阅了同行评审文献、监管指南文件和技术检验研究，以确保技术说明和效能考量反映当前的最佳实践。

在可能的情况下，方法评估包括独立的实验室性能研究以及与已发表的熟练度测试结果的交叉验证，以评估实际检测方法在各种样品基质中的稳健性。供应炼和关税影响评估参考了贸易数据模式和采购案例，以了解其对营运的影响。所有结果均经过品质检查和内部同行评审，以识别不一致之处并清晰解释假设和限制。虽然这种方法强调深度和适用性，但读者应注意，具体的营运结果可能会因实验室、司法管辖区的要求以及不断发展的技术能力而有所不同。

简明综合了技术、营运和供应链要素，这些要素决定了在不断发展的大肠桿菌检测环境中的成功

总而言之，大肠桿菌检测正处于实践创新阶段，分子诊断、生物感测和数位整合技术的进步再形成相关人员管理检测、回应和合规性的方式。重点正从独立的分析性能指标转向仪器、套件、试剂和软体如何满足工作流程和监管要求，并提供及时可靠的结果。供应链弹性和供应商弹性已成为策略要务，尤其是在关税相关压力和全球物流复杂性的背景下。

随着临床、食品和水处理领域采用途径的多样化，那些投资于相关样本类型的稳健验证、投资于可互通的数位系统并培养区域供应服务能力的组织将能够更好地满足不断增长的期望。竞争格局青睐那些将强大的分析绩效与可靠的支援、清晰的检验证据和灵活的采购选项相结合的产品，以降低最终用户的整体营运风险。依照这些优先事项采取行动的相关人员将提高其检测和应对污染事件的能力，保护公众健康，并更有信心地保持合规性。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 在整个食品加工厂实施基于 PCR 的快速大肠桿菌检测方法
  • 整合支援物联网的线上感测器，用于即时监测供水网路中的大肠桿菌
  • 用于现场食品安全检查和审核的可携式大肠桿菌检测设备的兴起
  • 使用基于 CRISPR 的检测方法在临床诊断中对大肠桿菌进行超灵敏检测
  • 扩大自动化和人工智慧驱动的筛检系统，用于大型酪农的大肠桿菌监测
  • 推进法规标准化生鲜食品供应链中的大肠桿菌阈值检测要求
  • 开发用于同时检测大肠桿菌和其他病原体的多路復用微流体平台
  • 加强生物技术与农业公司之间的伙伴关係，创造创新解决方案
  • 对基于区块链的可追溯性解决方案的需求日益增长，用于追踪肉类加工过程中的大肠桿菌污染事件
  • 智慧型手机整合生物感测器在休閒和环境水域现场大肠桿菌检测方面的进展

第六章 2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章大肠桿菌检测市场（依检测方法）

  • 生物感测器
  • 传统文化
  • 免疫检测
  • 分子检测
    • 数位PCR
    • PCR
    • 即时PCR

9. 大肠桿菌检测市场（依最终用户）

  • 学术研究
  • 临床诊断
    • 诊断实验室
    • 医院
  • 食品工业
    • 乳製品
    • 肉类和家禽
    • 加工食品
  • 水质检测
    • 饮用水
    • 污水

第 10 章大肠桿菌检测市场（依产品类型）

  • 装置
  • 套件
  • 试剂

第 11 章大肠桿菌检测市场（依技术）

  • 层析法
  • 酵素结合免疫吸附试验
  • 质谱法
  • 聚合酵素链锁反应

第 12 章大肠桿菌检测市场（依样本类型）

  • 临床样本
  • 食品样品
  • 水样

第十三章大肠桿菌检测市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 14 章大肠桿菌检测市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 15 章。按国家/地区分類的大肠桿菌检测市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Thermo Fisher Scientific Inc.
    • bioMerieux SA
    • Merck KGaA
    • 3M Company
    • Danaher Corporation
    • IDEXX Laboratories, Inc.
    • Neogen Corporation
    • Becton Dickinson and Company
    • Eurofins Scientific SE
    • QIAGEN NV
Product Code: MRR-4348D129FACF

The E. Coli Testing Market is projected to grow by USD 2.43 billion at a CAGR of 10.49% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.09 billion
Estimated Year [2025] USD 1.21 billion
Forecast Year [2032] USD 2.43 billion
CAGR (%) 10.49%

A comprehensive orientation to the evolving E coli testing environment emphasizing analytical rigor, operational resilience, and cross-sector applicability

E. coli remains a cornerstone organism for public health surveillance, clinical diagnostics, and food and water safety monitoring, demanding an integrated testing ecosystem that spans rapid on-site detection and high-sensitivity laboratory confirmation. Over the past decade, technological advancements have compressed turnaround times while regulatory expectations and consumer scrutiny have simultaneously intensified, creating a landscape in which accuracy, speed, and traceability drive procurement and R&D decisions. Laboratories and end users must now evaluate not only analytical performance but also operational factors such as throughput, ease of use, supply resilience, and long-term total cost of ownership. These considerations are particularly acute where diagnostic outcomes inform clinical interventions, where contamination events trigger recalls, or where water utilities must demonstrate compliance to protect public health.

Moving from broad surveillance to targeted mitigation requires a clearer understanding of how test methods perform across sample types and settings, and how product types and technologies interplay with workflow realities. As stakeholders increasingly demand interoperability, digital data capture, and standardized reporting, investment priorities are shifting toward solutions that can be validated across matrices and integrated into enterprise systems. Consequently, market participants who can marry robust assay performance with scalable instrumentation and dependable consumables will be better positioned to meet the converging needs of regulators, clinicians, and supply chain partners. The introduction of more portable molecular platforms and enhanced biosensing methods further expands application pathways, but also necessitates careful evaluation of validation evidence and quality assurance practices before widespread adoption.

Key systemic shifts reshaping E coli testing through decentralization of molecular diagnostics, enhanced biosensing, and integrated digital workflows

The past several years have seen transformative shifts that are redefining how E. coli testing is conceived, procured, and operationalized across laboratories and field settings. Rapid molecular techniques that once resided solely in centralized labs have migrated toward near-patient and on-site applications, challenging traditional roles for culture-based confirmation while enabling faster decision-making in outbreak scenarios. Concurrently, biosensor technologies have advanced to support real-time screening in supply chains and utilities, offering continuous monitoring capabilities that reduce detection latency and improve situational awareness.

In parallel, the convergence of digital data management and laboratory automation has created new pathways to scale high-throughput testing without proportionate increases in staffing. This digital backbone supports improved traceability, facilitates regulatory reporting, and helps harmonize results across disparate end users. Meanwhile, reagent and kit innovation have focused on simplifying workflows and improving robustness across varied sample matrices, making it easier to translate laboratory assays into field-friendly formats. Regulatory landscapes and accreditation requirements are also shifting to acknowledge rapid molecular and immunoassay modalities, prompting vendors and laboratories to invest in validation frameworks that align with evolving guidance. Taken together, these shifts are prompting portfolio realignment among suppliers and encouraging end users to re-evaluate their testing strategies to combine speed, accuracy, and operational efficiency.

Assessment of how tariff-driven supply-chain pressures are prompting strategic supplier diversification, nearshoring, and strengthened procurement safeguards

The introduction of new tariff measures in the United States has created a notable ripple effect through the E. coli testing ecosystem, affecting procurement strategies and supply-chain planning for instruments, kits, and reagents. Increased import duties on certain laboratory equipment and critical consumables have prompted buyers to reassess supplier diversification, accelerate qualification of alternative manufacturers, and explore domestic sourcing or nearshoring options to mitigate exposure to fluctuating cross-border costs. This recalibration has implications for both vendors and end users, as procurement cycles lengthen while stakeholders seek contracts that provide price stability and inventory assurance.

Moreover, the tariff environment has influenced investment decisions related to localized manufacturing capacity and distribution partnerships. Organizations with flexible supplier networks and established regional distributors have gained relative advantage in sustaining deliveries and maintaining service levels. At the same time, the need to maintain compliance with regulatory standards has constrained rapid substitution of components, compelling laboratory managers to invest in validation activities when qualifying new suppliers. Overall, the cumulative impact of tariffs has underscored the importance of supply-chain resilience, contractual risk-sharing, and proactive inventory management to ensure uninterrupted testing operations across clinical, food, and water testing contexts.

In-depth segmentation analysis revealing how test methods, end-user demands, product types, technologies, and sample matrices determine adoption and validation priorities

Understanding the market requires careful attention to how test methods, end users, product types, technology choices, and sample types interact to shape adoption pathways and investment priorities. With respect to test methods, the landscape spans biosensors, conventional culture, immunoassays, and molecular assays; within molecular approaches, techniques such as digital PCR, PCR, and real-time PCR each present distinct trade-offs between sensitivity, throughput, and operational complexity. These differences influence which settings favor rapid point-of-need screening versus centralized confirmation.

When examining end-user dynamics, the market includes academic research, clinical diagnostics, the food industry, and water testing. Clinical diagnostics further subdivides into diagnostic laboratories and hospitals, each with unique regulatory and workflow constraints. The food industry encompasses dairy, meat and poultry, and processed foods, where time-to-result and recall risk drive interest in rapid screening. Water testing is segmented into drinking water and wastewater monitoring, with differing sample matrices and compliance regimes that affect method selection. Across product types, instruments, kits, and reagents form the backbone of solution offerings, and procurement decisions often balance capital investment against consumable costs and service commitments. From a technology perspective, foundational analytical platforms such as chromatography, enzyme-linked immunosorbent assays, mass spectrometry, and polymerase chain reaction underpin testing strategies, with choices informed by matrix complexity and the need for confirmatory evidence. Finally, sample types-clinical, food, and water samples-present variable pre-analytical demands and inhibition profiles, requiring tailored extraction, enrichment, and validation approaches to ensure reliable detection. The interplay among these segmentation dimensions guides adoption, prioritizes innovation, and frames customer value propositions across market actors.

Comparative regional outlook highlighting how regulatory frameworks, infrastructure investment, and market maturity determine testing adoption across global regions

Regional dynamics shape both demand and capability for E. coli testing, driven by differences in regulatory regimes, supply-chain infrastructures, and public-health priorities. In the Americas, a mature diagnostics ecosystem and established regulatory pathways support rapid uptake of molecular assays and automated platforms, while the region also faces pressures to modernize water monitoring systems and strengthen food safety surveillance. The presence of large centralized laboratories coexists with growing interest in decentralised testing solutions to improve response times in outbreak scenarios.

Across Europe, the Middle East & Africa, regulatory harmonization efforts and varied market maturity levels create a complex environment where adoption rates for advanced technologies can differ markedly by country. Investment in water utilities and food safety programs is becoming a higher priority in several jurisdictions, which in turn fuels demand for both laboratory-confirmatory techniques and in-field screening tools. In the Asia-Pacific region, rapid industrialization and expanding consumer markets are driving heightened demand for food and water testing, while significant investments in laboratory infrastructure and domestic manufacturing capacity are accelerating the introduction of new testing platforms. These regional contrasts emphasize the importance of tailoring market entry, regulatory strategy, and supply-chain approaches to local conditions to maximize uptake and ensure sustained service levels.

Strategic competitive patterns showing how innovation, service integration, and regulatory readiness are shaping vendor advantage in E coli testing

Competitive dynamics in the E. coli testing domain are characterized by a blend of technology-driven differentiation and service-oriented value propositions. Key market participants are focusing on platform integration, supply-chain stability, and partnerships with end users in clinical, food, and water sectors to embed their solutions into routine workflows. Investment activity has emphasized expanding molecular diagnostic portfolios, enhancing biosensor performance for field applications, and developing consumables that reduce hands-on time and complexity. Strategic alliances between instrument suppliers and consumable manufacturers are common as vendors aim to offer end-to-end solutions that simplify validation and purchasing decisions for laboratories.

At the same time, companies are investing in regulatory and quality systems to support market entry across diverse jurisdictions, recognizing that localized approvals and demonstrated performance in matrix-specific studies influence buyer confidence. Service offerings, including maintenance contracts, remote diagnostics, and training programs, have become differentiators that reduce operational risk for customers. Firms that can provide robust evidence of analytical performance alongside responsive regional support and predictable supply chains tend to command priority in procurement cycles. Continued innovation in assay chemistry, sample processing, and data integration will likely drive the next wave of competitive advantage as buyers seek solutions that holistically address speed, accuracy, and operational resilience.

Practical strategies for suppliers and end users to build resilience, accelerate adoption, and strengthen validation and support capabilities across testing pathways

Industry leaders can take decisive actions to strengthen their positions by aligning investment and operational strategies with evolving end-user expectations and supply-chain realities. First, diversifying supplier networks and qualifying alternate manufacturers for critical instruments, kits, and reagents will reduce exposure to tariff volatility and logistics disruption while shortening recovery timelines during supply interruptions. Second, investing in molecular assay capability-particularly platforms that balance sensitivity with ease of use-enables accelerated decision-making in clinical and food-safety contexts and supports decentralization of testing without sacrificing confirmation pathways.

Third, prioritizing validation studies across the full range of relevant sample types and technologies, including comparisons between biosensors, immunoassays, chromatography, mass spectrometry, and PCR-based methods, enhances buyer confidence and eases regulatory submissions. Fourth, strengthening service and digital integration-through remote monitoring, predictive maintenance, and interoperable data formats-improves uptime and traceability. Fifth, targeting regional manufacturing or distribution partnerships in key markets can shorten supply lines and improve responsiveness to local regulatory requirements. Finally, fostering collaborative programs with water utilities, food processors, hospitals, and public health agencies to co-develop workflows and training programs will accelerate adoption and establish the organization as a trusted partner in risk mitigation and outbreak response.

Rigorous, multi-method research framework combining primary interviews, literature synthesis, validation cross-checks, and supply-chain analysis to ensure actionable insights

The research underpinning this analysis was assembled through a multi-method approach designed to triangulate insights from diverse sources while ensuring analytical rigor and reproducibility. Primary data collection included structured interviews with laboratory directors, procurement leads, regulatory specialists, and R&D scientists across clinical, food, and water testing environments to capture operational constraints, validation practices, and procurement drivers. These qualitative inputs were complemented by a comprehensive review of peer-reviewed literature, regulatory guidance documents, and technical validation studies to ensure that technological descriptions and performance considerations reflect current best practices.

Where possible, methodological evaluation included cross-validation against independent laboratory performance studies and published proficiency testing outcomes to assess real-world assay robustness across different sample matrices. Supply-chain and tariff impact assessments were informed by trade data patterns and procurement case studies to understand operational implications. All findings were subjected to quality checks and internal peer review to identify inconsistencies and ensure clear articulation of assumptions and limitations. While the approach emphasizes depth and applicability, readers should note that specific operational outcomes may vary by laboratory, jurisdictional requirements, and evolving technology performance; therefore, organizations are encouraged to undertake their own validation and procurement diligence aligned to local regulatory standards.

Concise synthesis of the technological, operational, and supply-chain imperatives that will determine success in the evolving E coli testing landscape

In sum, E. coli testing is undergoing a period of pragmatic innovation where advances in molecular diagnostics, biosensing, and digital integration are reshaping how stakeholders manage detection, response, and compliance. The focus is shifting from isolated analytical performance metrics to a broader emphasis on operational fit-how instruments, kits, reagents, and software integrate with workflows and regulatory expectations to deliver timely, trustworthy results. Supply-chain resilience and supplier flexibility have emerged as strategic imperatives, particularly in light of tariff-related pressures and global logistics complexity.

As adoption pathways become more varied across clinical, food, and water sectors, organizations that invest in robust validation across relevant sample types, invest in interoperable digital systems, and cultivate regional supply and service capabilities are better positioned to meet rising expectations. The competitive landscape rewards offerings that reduce total operational risk for end users by combining strong analytical performance with dependable support, clear validation evidence, and adaptable procurement options. Stakeholders that act on these priorities will improve their ability to detect and respond to contamination events, protect public health, and maintain regulatory compliance with greater confidence.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of rapid PCR-based E. coli detection methods across food processing facilities
  • 5.2. Integration of IoT-enabled inline sensors for real-time E. coli monitoring in water distribution networks
  • 5.3. Growth of portable E. coli testing devices for field-based food safety inspections and audits
  • 5.4. Utilization of CRISPR-based assays for ultra-sensitive detection of E. coli in clinical diagnostics
  • 5.5. Expansion of automation and AI-driven screening systems for E. coli surveillance in large-scale dairies
  • 5.6. Regulatory push toward standardized E. coli threshold testing requirements in fresh produce supply chains
  • 5.7. Development of multiplex microfluidic platforms enabling simultaneous detection of E. coli and other pathogens
  • 5.8. Increasing partnerships between biotech firms and agriculture companies to innovate E. coli testing solutions
  • 5.9. Rising demand for blockchain-enabled traceability solutions to track E. coli contamination events in meat processing
  • 5.10. Advancements in smartphone-integrated biosensors for on-site E. coli detection in recreational and environmental waters

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. E. Coli Testing Market, by Test Method

  • 8.1. Biosensors
  • 8.2. Conventional Culture
  • 8.3. Immunoassays
  • 8.4. Molecular Assays
    • 8.4.1. Digital Pcr
    • 8.4.2. Pcr
    • 8.4.3. Real-Time Pcr

9. E. Coli Testing Market, by End User

  • 9.1. Academic Research
  • 9.2. Clinical Diagnostics
    • 9.2.1. Diagnostic Labs
    • 9.2.2. Hospitals
  • 9.3. Food Industry
    • 9.3.1. Dairy
    • 9.3.2. Meat And Poultry
    • 9.3.3. Processed Foods
  • 9.4. Water Testing
    • 9.4.1. Drinking Water
    • 9.4.2. Wastewater

10. E. Coli Testing Market, by Product Type

  • 10.1. Instruments
  • 10.2. Kits
  • 10.3. Reagents

11. E. Coli Testing Market, by Technology

  • 11.1. Chromatography
  • 11.2. Enzyme-Linked Immunosorbent Assay
  • 11.3. Mass Spectrometry
  • 11.4. Polymerase Chain Reaction

12. E. Coli Testing Market, by Sample Type

  • 12.1. Clinical Samples
  • 12.2. Food Samples
  • 12.3. Water Samples

13. E. Coli Testing Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. E. Coli Testing Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. E. Coli Testing Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Thermo Fisher Scientific Inc.
    • 16.3.2. bioMerieux SA
    • 16.3.3. Merck KGaA
    • 16.3.4. 3M Company
    • 16.3.5. Danaher Corporation
    • 16.3.6. IDEXX Laboratories, Inc.
    • 16.3.7. Neogen Corporation
    • 16.3.8. Becton Dickinson and Company
    • 16.3.9. Eurofins Scientific SE
    • 16.3.10. QIAGEN N.V.

LIST OF FIGURES

  • FIGURE 1. GLOBAL E. COLI TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL E. COLI TESTING MARKET SIZE, BY TEST METHOD, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL E. COLI TESTING MARKET SIZE, BY TEST METHOD, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL E. COLI TESTING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL E. COLI TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL E. COLI TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL E. COLI TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL E. COLI TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL E. COLI TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL E. COLI TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL E. COLI TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL E. COLI TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS E. COLI TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA E. COLI TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA E. COLI TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE E. COLI TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST E. COLI TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA E. COLI TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL E. COLI TESTING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN E. COLI TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC E. COLI TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION E. COLI TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS E. COLI TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 E. COLI TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO E. COLI TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL E. COLI TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. E. COLI TESTING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. E. COLI TESTING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. E. COLI TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL E. COLI TESTING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL E. COLI TESTING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL E. COLI TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL E. COLI TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL E. COLI TESTING MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL E. COLI TESTING MARKET SIZE, BY BIOSENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL E. COLI TESTING MARKET SIZE, BY BIOSENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL E. COLI TESTING MARKET SIZE, BY BIOSENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL E. COLI TESTING MARKET SIZE, BY BIOSENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL E. COLI TESTING MARKET SIZE, BY BIOSENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL E. COLI TESTING MARKET SIZE, BY CONVENTIONAL CULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL E. COLI TESTING MARKET SIZE, BY CONVENTIONAL CULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL E. COLI TESTING MARKET SIZE, BY CONVENTIONAL CULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL E. COLI TESTING MARKET SIZE, BY CONVENTIONAL CULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL E. COLI TESTING MARKET SIZE, BY CONVENTIONAL CULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL E. COLI TESTING MARKET SIZE, BY CONVENTIONAL CULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL E. COLI TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL E. COLI TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL E. COLI TESTING MARKET SIZE, BY IMMUNOASSAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL E. COLI TESTING MARKET SIZE, BY IMMUNOASSAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL E. COLI TESTING MARKET SIZE, BY IMMUNOASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL E. COLI TESTING MARKET SIZE, BY IMMUNOASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL E. COLI TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL E. COLI TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL E. COLI TESTING MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL E. COLI TESTING MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL E. COLI TESTING MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL E. COLI TESTING MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL E. COLI TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL E. COLI TESTING MARKET SIZE, BY PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL E. COLI TESTING MARKET SIZE, BY PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL E. COLI TESTING MARKET SIZE, BY PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL E. COLI TESTING MARKET SIZE, BY PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL E. COLI TESTING MARKET SIZE, BY PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL E. COLI TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL E. COLI TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL E. COLI TESTING MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL E. COLI TESTING MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL E. COLI TESTING MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL E. COLI TESTING MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL E. COLI TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL E. COLI TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL E. COLI TESTING MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL E. COLI TESTING MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL E. COLI TESTING MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL E. COLI TESTING MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL E. COLI TESTING MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL E. COLI TESTING MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL E. COLI TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL E. COLI TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL E. COLI TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL E. COLI TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL E. COLI TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL E. COLI TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL E. COLI TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL E. COLI TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL E. COLI TESTING MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL E. COLI TESTING MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL E. COLI TESTING MARKET SIZE, BY DIAGNOSTIC LABS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL E. COLI TESTING MARKET SIZE, BY DIAGNOSTIC LABS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL E. COLI TESTING MARKET SIZE, BY DIAGNOSTIC LABS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL E. COLI TESTING MARKET SIZE, BY DIAGNOSTIC LABS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL E. COLI TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL E. COLI TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL E. COLI TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL E. COLI TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL E. COLI TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL E. COLI TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL E. COLI TESTING MARKET SIZE, BY FOOD INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL E. COLI TESTING MARKET SIZE, BY FOOD INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL E. COLI TESTING MARKET SIZE, BY FOOD INDUSTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL E. COLI TESTING MARKET SIZE, BY FOOD INDUSTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL E. COLI TESTING MARKET SIZE, BY FOOD INDUSTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL E. COLI TESTING MARKET SIZE, BY FOOD INDUSTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL E. COLI TESTING MARKET SIZE, BY FOOD INDUSTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL E. COLI TESTING MARKET SIZE, BY FOOD INDUSTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL E. COLI TESTING MARKET SIZE, BY DAIRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL E. COLI TESTING MARKET SIZE, BY DAIRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL E. COLI TESTING MARKET SIZE, BY DAIRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL E. COLI TESTING MARKET SIZE, BY DAIRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL E. COLI TESTING MARKET SIZE, BY DAIRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL E. COLI TESTING MARKET SIZE, BY DAIRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL E. COLI TESTING MARKET SIZE, BY MEAT AND POULTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL E. COLI TESTING MARKET SIZE, BY MEAT AND POULTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL E. COLI TESTING MARKET SIZE, BY MEAT AND POULTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL E. COLI TESTING MARKET SIZE, BY MEAT AND POULTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL E. COLI TESTING MARKET SIZE, BY MEAT AND POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL E. COLI TESTING MARKET SIZE, BY MEAT AND POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL E. COLI TESTING MARKET SIZE, BY PROCESSED FOODS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL E. COLI TESTING MARKET SIZE, BY PROCESSED FOODS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL E. COLI TESTING MARKET SIZE, BY PROCESSED FOODS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL E. COLI TESTING MARKET SIZE, BY PROCESSED FOODS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL E. COLI TESTING MARKET SIZE, BY PROCESSED FOODS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL E. COLI TESTING MARKET SIZE, BY PROCESSED FOODS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL E. COLI TESTING MARKET SIZE, BY WATER TESTING, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL E. COLI TESTING MARKET SIZE, BY WATER TESTING, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL E. COLI TESTING MARKET SIZE, BY WATER TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL E. COLI TESTING MARKET SIZE, BY WATER TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL E. COLI TESTING MARKET SIZE, BY WATER TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL E. COLI TESTING MARKET SIZE, BY WATER TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL E. COLI TESTING MARKET SIZE, BY WATER TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL E. COLI TESTING MARKET SIZE, BY WATER TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL E. COLI TESTING MARKET SIZE, BY DRINKING WATER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL E. COLI TESTING MARKET SIZE, BY DRINKING WATER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL E. COLI TESTING MARKET SIZE, BY DRINKING WATER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL E. COLI TESTING MARKET SIZE, BY DRINKING WATER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL E. COLI TESTING MARKET SIZE, BY DRINKING WATER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL E. COLI TESTING MARKET SIZE, BY DRINKING WATER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL E. COLI TESTING MARKET SIZE, BY WASTEWATER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL E. COLI TESTING MARKET SIZE, BY WASTEWATER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL E. COLI TESTING MARKET SIZE, BY WASTEWATER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL E. COLI TESTING MARKET SIZE, BY WASTEWATER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL E. COLI TESTING MARKET SIZE, BY WASTEWATER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL E. COLI TESTING MARKET SIZE, BY WASTEWATER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL E. COLI TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL E. COLI TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL E. COLI TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL E. COLI TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL E. COLI TESTING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL E. COLI TESTING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL E. COLI TESTING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL E. COLI TESTING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL E. COLI TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL E. COLI TESTING MARKET SIZE, BY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL E. COLI TESTING MARKET SIZE, BY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL E. COLI TESTING MARKET SIZE, BY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL E. COLI TESTING MARKET SIZE, BY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL E. COLI TESTING MARKET SIZE, BY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL E. COLI TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL E. COLI TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL E. COLI TESTING MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL E. COLI TESTING MARKET SIZE, BY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL E. COLI TESTING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL E. COLI TESTING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL E. COLI TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL E. COLI TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL E. COLI TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL E. COLI TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL E. COLI TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL E. COLI TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL E. COLI TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL E. COLI TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL E. COLI TESTING MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL E. COLI TESTING MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL E. COLI TESTING MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL E. COLI TESTING MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL E. COLI TESTING MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL E. COLI TESTING MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL E. COLI TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL E. COLI TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL E. COLI TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL E. COLI TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL E. COLI TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL E. COLI TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL E. COLI TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL E. COLI TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL E. COLI TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL E. COLI TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL E. COLI TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL E. COLI TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL E. COLI TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL E. COLI TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL E. COLI TESTING MARKET SIZE, BY CLINICAL SAMPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL E. COLI TESTING MARKET SIZE, BY CLINICAL SAMPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL E. COLI TESTING MARKET SIZE, BY CLINICAL SAMPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL E. COLI TESTING MARKET SIZE, BY CLINICAL SAMPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL E. COLI TESTING MARKET SIZE, BY CLINICAL SAMPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL E. COLI TESTING MARKET SIZE, BY CLINICAL SAMPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL E. COLI TESTING MARKET SIZE, BY FOOD SAMPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL E. COLI TESTING MARKET SIZE, BY FOOD SAMPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL E. COLI TESTING MARKET SIZE, BY FOOD SAMPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL E. COLI TESTING MARKET SIZE, BY FOOD SAMPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL E. COLI TESTING MARKET SIZE, BY FOOD SAMPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL E. COLI TESTING MARKET SIZE, BY FOOD SAMPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL E. COLI TESTING MARKET SIZE, BY WATER SAMPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL E. COLI TESTING MARKET SIZE, BY WATER SAMPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL E. COLI TESTING MARKET SIZE, BY WATER SAMPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL E. COLI TESTING MARKET SIZE, BY WATER SAMPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL E. COLI TESTING MARKET SIZE, BY WATER SAMPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL E. COLI TESTING MARKET SIZE, BY WATER SAMPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL E. COLI TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL E. COLI TESTING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS E. COLI TESTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS E. COLI TESTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS E. COLI TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS E. COLI TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS E. COLI TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS E. COLI TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS E. COLI TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS E. COLI TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS E. COLI TESTING MARKET SIZE, BY FOOD INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS E. COLI TESTING MARKET SIZE, BY FOOD INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS E. COLI TESTING MARKET SIZE, BY WATER TESTING, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS E. COLI TESTING MARKET SIZE, BY WATER TESTING, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS E. COLI TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS E. COLI TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS E. COLI TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS E. COLI TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS E. COLI TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS E. COLI TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA E. COLI TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA E. COLI TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA E. COLI TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA E. COLI TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA E. COLI TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA E. COLI TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA E. COLI TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA E. COLI TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA E. COLI TESTING MARKET SIZE, BY FOOD INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA E. COLI TESTING MARKET SIZE, BY FOOD INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA E. COLI TESTING MARKET SIZE, BY WATER TESTING, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA E. COLI TESTING MARKET SIZE, BY WATER TESTING, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA E. COLI TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA E. COLI TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA E. COLI TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA E. COLI TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA E. COLI TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA E. COLI TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA E. COLI TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA E. COLI TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA E. COLI TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA E. COLI TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA E. COLI TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA E. COLI TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA E. COLI TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA E. COLI TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA E. COLI TESTING MARKET SIZE, BY FOOD INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA E. COLI TESTING MARKET SIZE, BY FOOD INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA E. COLI TESTING MARKET SIZE, BY WATER TESTING, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA E. COLI TESTING MARKET SIZE, BY WATER TESTING, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA E. COLI TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA E. COLI TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA E. COLI TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA E. COLI TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA E. COLI TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA E. COLI TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY FOOD INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY FOOD INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY WATER TESTING, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY WATER TESTING, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE E. COLI TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE E. COLI TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE E. COLI TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE E. COLI TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE E. COLI TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE E. COLI TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE E. COLI TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE E. COLI TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE E. COLI TESTING MARKET SIZE, BY FOOD INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE E. COLI TESTING MARKET SIZE, BY FOOD INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE E. COLI TESTING MARKET SIZE, BY WATER TESTING, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE E. COLI TESTING MARKET SIZE, BY WATER TESTING, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE E. COLI TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE E. COLI TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE E. COLI TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE E. COLI TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE E. COLI TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE E. COLI TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST E. COLI TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST E. COLI TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST E. COLI TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 296. MIDDLE EAST E. COLI TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, 2018-2024 (USD MILLION)
  • TABLE 298. MIDDLE EAST E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST E. COLI TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. MIDDLE EAST E. COLI TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST E. COLI TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 302. MIDDLE EAST E. COLI TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST E. COLI TESTING MARKET SIZE, BY FOOD INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 304. MIDDLE EAST E. COLI TESTING MARKET SIZE, BY FOOD INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 305. MIDDLE EAST E. COLI TESTING MARKET SIZE, BY WATER TESTING, 2018-2024 (USD MILLION)
  • TABLE 306. MIDDLE EAST E. COLI TESTING MARKET SIZE, BY WATER TESTING, 2025-2032 (USD MILLION)
  • TABLE 307. MIDDLE EAST E. COLI TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. MIDDLE EAST E. COLI TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. MIDDLE EAST E. COLI TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 310. MIDDLE EAST E. COLI TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 311. MIDDLE EAST E. COLI TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. MIDDLE EAST E. COLI TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 313. AFRICA E. COLI TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. AFRICA E. COLI TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. AFRICA E. COLI TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 316. AFRICA E. COLI TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 317. AFRICA E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, 2018-2024 (USD MILLION)
  • TABLE 318. AFRICA E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, 2025-2032 (USD MILLION)
  • TABLE 319. AFRICA E. COLI TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 320. AFRICA E. COLI TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 321. AFRICA E. COLI TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 322. AFRICA E. COLI TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 323. AFRICA E. COLI TESTING MARKET SIZE, BY FOOD INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 324. AFRICA E. COLI TESTING MARKET SIZE, BY FOOD INDUSTRY, 2025-2032 (USD MILLION)
  • TABLE 325. AFRICA E. COLI TESTING MARKET SIZE, BY WATER TESTING, 2018-2024 (USD MILLION)
  • TABLE 326. AFRICA E. COLI TESTING MARKET SIZE, BY WATER TESTING, 2025-2032 (USD MILLION)
  • TABLE 327. AFRICA E. COLI TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 328. AFRICA E. COLI TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 329. AFRICA E. COLI TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 330. AFRICA E. COLI TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 331. AFRICA E. COLI TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 332. AFRICA E. COLI TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 333. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 334. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 335. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 336. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 337. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, 2018-2024 (USD MILLION)
  • TABLE 338. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY MOLECULAR ASSAYS, 2025-2032 (USD MILLION)
  • TABLE 339. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 340. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY END USER, 2025-2032 (U